Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure, Inc. (ATRC)
:ATRC
Holding ATRC?
Track your performance easily
ATRC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$18.94 - $39.12
Previous CloseN/A
Volume180.64K
Average Volume (3M)476.26K
Market Cap
$1.84B
Enterprise Value$1.27B
Total Cash (Recent Filing)$44.01M
Total Debt (Recent Filing)$37.20M
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Feb 25, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.83
Shares Outstanding48,753,250
10 Day Avg. Volume714,202
30 Day Avg. Volume476,258
Standard Deviation0.13
R-Squared0.34
Alpha-0.00934
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.10
Price to Cash Flow (P/CF)22.90
P/FCF Ratio27.70
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue2.83
Enterprise Value/Gross Profit4.22
Enterprise Value/Ebitda-81.51
Forecast
1Y Price Target
$47.14Price Target Upside25.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Atricure News
PremiumCompany Announcements
AtriCure Projects Strong Revenue Growth for 2024
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAtriCure sales exceeded expectations with better-than-expected US and international performance driving the quarter's upside.
Product InnovationAtriCure's new product innovation engine is helping drive better pricing, share-gains, and improved market growth.
Revenue GrowthAtriCure preannounced above-consensus 4Q24 revenue of $124.3M, showing a 17% year-over-year growth.
Bears Say
Growth SlowdownMinimally Invasive Ablation growth slowed due to pressure from PFA procedure volume.
Guidance ReductionThe company lowered full-year 2024 guidance by approximately $4 million due to the relative softness within its MIS Ablation and MIS Appendage Management segments.
Market DynamicsThe Minimally Invasive division came in just below consensus as market dynamics around the introduction of PFA continued.
---
Ownership Overview
3.17% Insiders
38.89% Mutual Funds
0.38% Other Institutional Investors
41.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATRC FAQ
What was Atricure, Inc.’s price range in the past 12 months?
Atricure, Inc. lowest stock price was $18.94 and its highest was $39.12 in the past 12 months.
What is Atricure, Inc.’s market cap?
Atricure, Inc.’s market cap is $1.84B.
When is Atricure, Inc.’s upcoming earnings report date?
Atricure, Inc.’s upcoming earnings report date is Feb 25, 2025 which is in 38 days.
How were Atricure, Inc.’s earnings last quarter?
Atricure, Inc. released its earnings results on Oct 29, 2024. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.195 by $0.025.
Is Atricure, Inc. overvalued?
According to Wall Street analysts Atricure, Inc.’s price is currently Undervalued.
Does Atricure, Inc. pay dividends?
Atricure, Inc. does not currently pay dividends.
What is Atricure, Inc.’s EPS estimate?
Atricure, Inc.’s EPS estimate is -0.2.
How many shares outstanding does Atricure, Inc. have?
Atricure, Inc. has 48,753,250 shares outstanding.
What happened to Atricure, Inc.’s price movement after its last earnings report?
Atricure, Inc. reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.195. Following the earnings report the stock price went up 18.349%.
Which hedge fund is a major shareholder of Atricure, Inc.?
Among the largest hedge funds holding Atricure, Inc.’s share is Royce & Associates LLC. It holds Atricure, Inc.’s shares valued at 2M.
---
Atricure Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.14 (25.24% Upside)
$47.14 (25.24% Upside)
Blogger Sentiment
Bullish
ATRC Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 28.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.14%
12-Months-Change
Fundamentals
Return on Equity
-8.39%
Trailing 12-Months
Asset Growth
2.46%
Trailing 12-Months
Company Description
Atricure, Inc.
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
---
ATRC Company Deck
---
ATRC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance for AtriCure with significant revenue growth and positive cash flow. However, there are challenges in maintaining gross margins and increasing operating expenses. While the company is seeing pressure in certain areas due to market dynamics, the overall outlook remains positive with continued investments in innovation and market expansion.Read More>---
ATRC Stock 12 Month Forecast
Average Price Target
$47.14
▲(25.24% Upside)
Technical Analysis
Staar Surgical
―
Inspire Medical Systems
―
Nevro Corp
―
AxoGen
―
Intuitive Surgical
―
Medtronic
―
Best Analysts Covering ATRC
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+45.01%
reiterated a buy rating 3 months ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +45.01% per trade.
---